Skip to main content
Retour
AFYA logo

Afya Limited

Qualité des données : 100%
AFYA
NASDAQ Consumer Defensive Education & Training Services
14,75 €
▼ 0,19 € (-1,27%)
Cap. Boursière : 1,33B
Fourchette du Jour
14,69 € 15,19 €
Fourchette 52 Semaines
13,00 € 19,90 €
Volume
104 478
Moyenne 50J / 200J
14,37 € / 15,12 €
Clôture Précédente
14,94 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Consumer Defensive (329 pairs)

Métrique Action Médiane du Secteur
P/E 1,8 10,5
P/B 0,3 1,3
ROE % 16,2 12,3
Net Margin % 20,4 5,3
Rev Growth 5Y % 20,5 5,5
D/E 0,6 0,6

Objectif de Cours des Analystes

Hold
16,33 € +10.7%
Low: 16,00 € High: 17,00 €
P/E Prévisionnel
1,62
BPA Prévisionnel
9,37 €
Croissance BPA (est.)
+0,0%
CA Est.
3,99B

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2028 0,00 €
0,00 € – 0,00 €
4,35B 1
FY2027 10,84 €
10,35 € – 11,32 €
4,27B 3
FY2026 9,37 €
8,95 € – 9,74 €
3,99B 3

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-03-12 0,33 € 0,41 € +23,4%
2025-11-12 0,32 € 0,38 € +18,8%
2025-08-13 0,40 € 0,40 € 0,0%
2025-05-08 0,46 € 0,55 € +19,6%
2025-03-13 0,34 € 0,36 € +5,9%
2024-11-13 0,36 € 0,32 € -11,1%
2024-08-15 0,37 € 0,44 € +18,9%
2024-05-09 0,47 € 0,55 € +17,0%

Dividend History

1 yr streak

Yield

0,02%

Payout Ratio

0,16%

Growth (3Y)

N/A

Growth (5Y)

N/A

Ex-Date Payment Date Amount Yield
Mar 25, 2026 Apr 06, 2026 0,66 € 4,33%
Mar 26, 2025 Apr 04, 2025 0,23 € 1,29%

Points Clés

Revenue grew 20,50% annually over 5 years — strong growth
Earnings grew 16,81% over the past year
ROE of 16,18% — decent returns on equity
Net margin of 20,35% shows strong profitability
Generating 1,04B in free cash flow
P/E of 1,81 — trading at a low valuation

Croissance

Revenue Growth (5Y)
20,50%
Revenue (1Y)9,69%
Earnings (1Y)16,81%
FCF Growth (3Y)13,95%

Qualité

Return on Equity
16,18%
ROIC11,20%
Net Margin20,35%
Op. Margin32,81%

Sécurité

Debt / Equity
0,64
Current Ratio2,20
Interest Coverage2,41

Valorisation

P/E Ratio
1,81
Forward P/E1,62
P/B Ratio0,28
EV/EBITDA2,80
Dividend Yield0,02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 9,69% Revenue Growth (3Y) 12,26%
Earnings Growth (1Y) 16,81% Earnings Growth (3Y) 38,18%
Revenue Growth (5Y) 20,50% Earnings Growth (5Y) 34,81%
Profitability
Revenue (TTM) 3,62B Net Income (TTM) 737,68M
ROE 16,18% ROA 7,89%
Gross Margin 64,46% Operating Margin 32,81%
Net Margin 20,35% Free Cash Flow (TTM) 1,04B
ROIC 11,20% FCF Growth (3Y) 13,95%
Safety
Debt / Equity 0,64 Current Ratio 2,20
Interest Coverage 2,41
Dividends
Dividend Yield 0,02% Payout Ratio 0,16%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years 1 yrs
Valuation
P/E Ratio 1,81 Forward P/E 1,62
P/B Ratio 0,28 P/S Ratio 0,37
PEG Ratio 0,63 Forward PEG N/A
EV/EBITDA 2,80 Fwd EV/EBITDA 2,28
Forward P/S 0,33 Fwd Earnings Yield 61,73%
FCF Yield 77,67%
Market Cap 1,33B Enterprise Value 3,33B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3,62B 3,30B 2,88B 2,33B 1,72B
Net Income 737,68M 631,51M 386,32M 373,57M 223,33M
EPS (Diluted) 8,11 6,93 4,27 4,15 2,37
Gross Profit 2,34B 2,09B 1,77B 1,47B 1,07B
Operating Income 1,19B 1,01B 767,06M 664,10M 440,90M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 9,35B 8,83B 7,58B 7,20B 6,45B
Total Liabilities 4,46B 4,52B 3,94B 3,95B 3,45B
Shareholders' Equity 4,85B 4,27B 3,60B 3,20B 2,95B
Total Debt 3,12B 3,17B 2,68B 2,71B 2,16B
Cash & Equivalents 1,12B 911,02M 553,03M 1,09B 748,56M
Current Assets 1,94B 1,59B 1,20B 1,64B 1,21B
Current Liabilities 883,60M 1,14B 1,06B 905,69M 766,51M

Scores de Stratégies

This stock passed the criteria for 5 strategies

Score = fit strength (0–100)
Rank = position among all matches
#296 of 1058
55
#98 of 225
44
#313 of 628
35
Custom Balanced Risk
#51 of 151
50
Custom Lower Risk
#98 of 139
40

Activité Récente

Sorti Contrarian Investing (David Dreman)
Mar 26, 2026
Entré Cash Flow Compounder
Mar 24, 2026
Entré Capital Light Compounder
Mar 24, 2026
Entré Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré Contrarian Investing (David Dreman)
Mar 24, 2026
Entré Balanced Risk
Mar 24, 2026
Entré Lower Risk
Mar 24, 2026